Atrás
También listada como
BMXXY
OTC
Rango del Día
$102.25
$115.00
Rango de 52 Semanas
$102.25
$152.00
Volumen
868
Promedio 50D / 200D
$117.87
/
$130.64
Cierre Anterior
$102.25
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 30.4 | 0.3 |
| P/B | 2.9 | 2.9 |
| ROE % | 9.6 | 3.7 |
| Net Margin % | 9.8 | 3.8 |
| Rev Growth 5Y % | 4.8 | 10.0 |
| D/E | 0.1 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$7.17
$7.01 – $7.49
|
5.4 B | 1 |
| FY2029 |
$6.61
$6.46 – $6.90
|
5.1 B | 1 |
| FY2028 |
$6.02
$5.89 – $6.29
|
4.8 B | 1 |
Puntos Clave
Revenue grew 4.77% annually over 5 years — modest growth
Debt/Equity of 0.11 — conservative balance sheet
Generating 452.83M in free cash flow
P/E of 30.38 — premium valuation
Cash machine — converts 113.96% of earnings into free cash flow
Capital efficient — spends only 8.24% of revenue on capex
Crecimiento
Revenue Growth (5Y)
4.77%
Revenue (1Y)2.22%
Earnings (1Y)-8.06%
FCF Growth (3Y)105.62%
Calidad
Return on Equity
9.57%
ROIC9.22%
Net Margin9.77%
Op. Margin13.79%
Seguridad
Debt / Equity
0.11
Current Ratio2.39
Interest Coverage0.00
Valoración
P/E Ratio
30.38
P/B Ratio2.94
EV/EBITDA21.33
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.22% | Revenue Growth (3Y) | 5.22% |
| Earnings Growth (1Y) | -8.06% | Earnings Growth (3Y) | 5.41% |
| Revenue Growth (5Y) | 4.77% | Earnings Growth (5Y) | -9.83% |
| Profitability | |||
| Revenue (TTM) | 4.07B | Net Income (TTM) | 397.35M |
| ROE | 9.57% | ROA | 7.13% |
| Gross Margin | 52.63% | Operating Margin | 13.79% |
| Net Margin | 9.77% | Free Cash Flow (TTM) | 452.83M |
| ROIC | 9.22% | FCF Growth (3Y) | 105.62% |
| Safety | |||
| Debt / Equity | 0.11 | Current Ratio | 2.39 |
| Interest Coverage | 0.00 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 30.38 | P/B Ratio | 2.94 |
| P/S Ratio | 2.97 | PEG Ratio | -3.99 |
| EV/EBITDA | 21.33 | Dividend Yield | 0.01% |
| Market Cap | 12.07B | Enterprise Value | 11.96B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.07B | 3.98B | 3.67B | 3.59B | 3.38B |
| Net Income | 397.35M | 432.20M | 357.60M | 452.40M | 601.10M |
| EPS (Diluted) | 3.34 | 3.64 | 3.01 | 3.82 | 5.06 |
| Gross Profit | 2.14B | 2.22B | 2.06B | 2.01B | 2.00B |
| Operating Income | 560.99M | 588.80M | 439.00M | 587.20M | 784.30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5.57B | 5.77B | 5.26B | 5.19B | 4.62B |
| Total Liabilities | 1.47B | 1.56B | 1.51B | 1.54B | 1.44B |
| Shareholders' Equity | 4.10B | 4.20B | 3.75B | 3.60B | 3.12B |
| Total Debt | 461.23M | 490.70M | 518.80M | 505.40M | 462.50M |
| Cash & Equivalents | 569.59M | 449.80M | 352.40M | 552.60M | 803.50M |
| Current Assets | 2.54B | 2.50B | 2.21B | 2.22B | 2.21B |
| Current Liabilities | 1.06B | 1.13B | 1.09B | 1.13B | 955.90M |